SMATERNAL PREGNANCY OUTCOMES IN WOMEN WITH CARDIOMYOPATHY: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/j1qfb369Keywords:
Cardiac disease, CARPREG, maternal cardiomyopathy, maternal outcomeAbstract
Introduction: Pregnancy poses significant cardiovascular challenges, affecting 1% to 4% of pregnancies due to maternal heart disease. Cardiomyopathies, leading indirect causes of maternal mortality globally, raise concerns during pregnancy, despite limited data on their impact and the accuracy of predictive scores like Carpreg and Zahara. Maternal heart disease, comprising hypertensive disorders and cardiomyopathies, presents substantial risks during pregnancies, driving increased maternal mortality rates. The evolving landscape, marked by improved survival in congenital heart disease and delayed pregnancies with associated comorbidities, necessitates a more nuanced understanding and comprehensive predictive models for tailored care during pregnancy.
Methods: The researchers in this study followed the 2020 Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) guidelines to ensure that their work met the required standards. This was done to ensure the precision and reliability of the conclusions derived from the research.
Result: Our search produced 15 results. After looking at the titles and summaries, we found 11 papers that fit our criteria. At first, we excluded several articles because they were written in review and case report style. But after reading the full papers carefully, we included five papers in our final analysis. These papers included prospective and retrospective studies.
Conclusion: The investigation of pregnant women in Canadian obstetric centers unveiled that cardiac issues affect 16% of pregnancies, primarily with arrhythmias and heart failure, even in lower-risk cases, with complications emerging before birth. The study's precision in evaluating pregnancy-related cardiac risks, leading to a new CARPREG II risk index and emphasizing tailored surveillance and timely referrals, was notable. The ROPAC registry highlighted higher maternal mortality rates, stressing vigilant management throughout pregnancy and after delivery, emphasizing the necessity for specialized care and research advancements in this field.
References
Eggleton EJ, McMurrugh KJ, Aiken CE. Maternal pregnancy outcomes in women with cardiomyopathy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;227(4):582-592. doi:10.1016/j.ajog.2022.05.039
Chattopadhyay R, Olwell B, Bhagra CJ. Maternal cardiac disease in pregnancy. Obstet Gynaecol Reprod Med 2022;32:1–7.
Billebeau G, Etienne M, Cheikh-Khelifa R, et al. Pregnancy in women with a cardiomyopathy: outcomes and predictors from a retrospective cohort. Arch Cardiovasc Dis 2018;111:199–209.
Owens A, Yang J, Nie L, Lima F, Avila C, Stergiopoulos K. Neonatal and maternal outcomes in pregnant women with cardiac disease. J Am Heart Assoc 2018;7:e009395.
Silversides CK, Grewal J, Mason J, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol 2018;71:2419–30.
Boulé S, Ovart L, Marquié C, et al. Pregnancy in women with an implantable cardioverterdefibrillator: is it safe? Europace 2014;16:1587–94.
Jolien Roos-Hesselink, Lucia Baris, Mark Johnson, Julie De Backer, Catherine Otto, Ariane Marelli, Guillaume Jondeau, Werner Budts, Jasmine Grewal, Karen Sliwa, William Parsonage, Aldo P Maggioni, Iris van Hagen, Alec Vahanian, Luigi Tavazzi, Uri Elkayam, Eric Boersma, Roger Hall, on behalf of the ROPAC Investigators,
Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry
Of Pregnancy And Cardiac disease (ROPAC), European Heart Journal, Volume 40, Issue 47, 14 December 2019, Pages 3848–3855, https://doi.org/10.1093/eurheartj/ehz136
Yokouchi-Konishi, T., Kamiya, C. A., Shionoiri, T., Nakanishi, A., Iwanaga, N., Izumi, C., … Yoshimatsu, J. (2020). Pregnancy outcomes in women with dilated cardiomyopathy: Peripartum cardiovascular events predict post delivery prognosis. Journal of Cardiology. doi:10.1016/j.jjcc.2020.07.007
Soomro S, Kumar R, Shaikh A A (October 30, 2019) Twenty-eight Pregnant Women with Cardiac Diseases: A Review of Maternal and Fetal Outcomes in Pakistan. Cureus 11(10): e6034. doi:10.7759/cureus.6034
Schaufelberger M: Cardiomyopathy and pregnancy. Heart. 2019, 105:1543-1551. 10.1136/heartjnl-2018313476
Mitchelson JB, Cleveland DE: Optimal management of a pregnant patient with rheumatic heart disease . Kans J Med. 2018, 11:80-82.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
